Researchers Seek Ways to Minimize Off-Target Effects
Literature Review: Dials for Cas9
Methods to Control Cas9-Based Technologies Across Numerous Dimensions Is Still Lacking
Opening Up Relieves Downstream Bottlenecks
Celebrate the Downstream Improvements That Have Been Achieved, Even If They Fail to Match Upstream Improvements
Top 10 European Biopharma Clusters
The Continent’s Key Academic and Industrial Centers for Drug Development
- Dolomite Microfluidics
- Unit 1, Anglian Business Park
- Orchard Rd.
- Royston , SG8 5TW
- UNITED KINGDOM
Dolomite has its roots in Syrris, which was founded in 2001 by Mark Gilligan and Richard Gray to address the challenges faced by the pharmaceutical industry. While Syrris focuses on flow chemistry and microreactors, Dolomite was set up as a subsidiary to provide microfluidic solutions to customers around the world in a very wide range of applications outside the field of research chemistry.